SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN) (http://www.BMSN.us) announced today it has entered into a Letter of Intent (LOI) with Therinject LLC contemplating the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immuno-therapeutic approaches.
